PFIZER
Executive Director – Drug Product Design & Development
Head – Nanoparticle Development
Membership Participation
Membership Participation
Participating in the Consortium
The activities and efforts of the Subcutaneous Drug Development and Delivery Consortium provide an opportunity for participating organizations to proactively impact and drive value across SC drug development and delivery and ultimately provide value to the larger community.
SC Consortium Officers:
Donna French, PhD
President
Sachin Mittal, PhD
Vice President
Monica Adams, PhD
Marketing Officer
David Kang, PhD
Treasurer
SC Consortium: Tier 1 Members
SC Consortium: Tier 2 Members
SC Consortium: Governing Board/Tier 1 Members
SHL Medical
Head of Innovation Strategy & Applied Research
ROCHE
Global Head Product Optimiatzation
SC Consortium CDRS Co-lead
Halozyme
Chief Medical Officer
Matchstick
Principal & Clinical Leader
HALOZYME
Associate Director, Drug Delivery
SC Consortium Treasurer
ASTRA ZENECA
Vice President, Dosage Form Design & Development
SC Consortium President
ASTRA ZENECA
Senior Director, Astra Zeneca
SC Consortium Sustainability Co-lead
The SC Consortium has been proudly engaging with Charles Rivers Associates since its inception in 2018
Robert Broadnax
NJ
Vice President
PROJECT LEAD
Brian Carpenter
NJ
Principal
PROJECT LEAD
Matthew Potter
NY
Senior Associate
ENGAGEMENT LEAD
Ella Brown
MA
Associate
PROJECT SUPPORT
© 2025 Subcutaneous Drug Development & Delivery Consortium
English